Congrats!!!

Yup that's me!

I think it has pros and cons. However, I do prefer to do my end of block feedback at the same time that I fill out my evals with the resident.

My categorical IM are 8+4 and my PCT (primary care) are 4+4. Our program sends out online evals every 4 week block.

Like this? journals.lww.com/jcehp/fullte...

15/ 🎧 For more episodes tackling Long COVID, check out our podcast on Spotify and Apple Podcasts. Stay informed!

open.spotify.com/show/03ZC9El...

podcasts.apple.com/us/podcast/t...

14/ 📣 Dive deeper into this discussion on Episode 6 of The Long COVID Clinical Podcast. Explore the links between ME/CFS and Long COVID, and learn about emerging treatments. Listen here: open.spotify.com/episode/4aJt...

13/ 🧠 Dr. Bonilla’s takeaway: "Listening to patients is critical. Many therapies, like naltrexone and Abilify, were inspired by patient experiences and deserve further study."

12/ 🌍 The bigger picture: Post-viral syndromes highlight gaps in our understanding of infection-associated chronic conditions. Research and collaboration are vital for progress.

11/ ⚠️ The risks of unregulated treatments: Desperate patients often turn to unproven therapies. Dr. Bonilla emphasizes the need for safe, evidence-based care and patient-centered support.

10/ Challenges: Lack of biomarkers limits diagnosis. ME/CFS is based on clinical criteria like fatigue, post-exertional malaise, and orthostatic intolerance. Long COVID follows a similar diagnostic path.

9/ 📖 Advocacy is key: Patients need validation and support. Recognizing ME/CFS and Long COVID as real, disabling conditions is a vital first step toward effective care and research.

8/ 🧬 Dr. Bonilla notes intriguing links between ME/CFS, Long COVID, and genetic predispositions, including hypermobility syndromes (e.g., Ehlers-Danlos). Why some patients develop these conditions while others don't remains a puzzle.